Browsing: Therapeutics
Exicure (NASDAQ:XCUR) entered into a Share Purchase Agreement with GPCR Therapeutics, a Korean corporation pursuant to which the company acquired…
Joao SerafimCiting preliminary financials, TG Therapeutics (NASDAQ:TGTX) announced Tuesday that the U.S. net sales from its multiple sclerosis therapy, Briumvi,…
Dyne Therapeutics (NASDAQ:DYN) reported clinical data from its ongoing Phase 1/2 trial of DYNE-101 in patients with myotonic dystrophy type…
Michael Vi/iStock Editorial via Getty Images Roche (OTCQX:RHHBY) (OTCQX:RHHBF) will finalize the acquisition of Poseida Therapeutics (NASDAQ:PSTX), a biopharmaceutical company…
designer491/iStock via Getty Images Stoke Therapeutics (NASDAQ:STOK) announced alignment with global regulatory agencies on the design of the company’s Phase…
shulz/E+ via Getty Images Exicure (NASDAQ:XCUR) signed a MOU with GPCR Therapeutics aimed at the acquisition of GPCR USA, a…
Shidlovski PTC Therapeutics (NASDAQ:PTCT) has submitted a New Drug Application to the U.S. FDA seeking approval of its Friedreich ataxia…